All News

Filter by

News Type
Topic
Language
Published Date

Filter by News Type

Done

Filter by Topic

Done

Filter by Language

Done

Filter by Published Date

Done
|
NHLBI in the Press
Dementia is the leading cause of dependence and disability in the elderly population worldwide. But currently there is no effective medication to treat dementia. Identifying lifestyle-related risk factors, including some that are modifiable, may provide important strategies for preventing dementia.
Scientist clare waterman working with microscope
|
NHLBI in the Press
Clare M. Waterman, Ph.D., NIH distinguished investigator and director of the NHLBI Laboratory of Cell and Tissue Morphodynamics has been elected to the National Academy of Sciences (NAS), the highest honor for American scholars in recognition of their distinguished and continuing achievements in ori
Set of asthma inhaler, accuhaler and anti-allergy pills for treatment asthma. Asthma controller, reliever equipment on dark background. Bronchodilator and steroids drug for severe asthma
|
Research Features
Here’s a sobering thought: Nearly half of Americans with severe asthma do not respond to conventional drugs, leaving them with few ways to minimize the often-debilitating symptoms of the chronic disease. But researchers at NHLBI have developed a new treatment that has the potential to dramatically change that: A synthetic peptide that mimics the wo...
Patient getting blood pressure measured with digital machine. Blood pressure digital and cuff on the desk.
|
Media Availability
WHAT: Hypertension—a major risk factor for heart disease, the leading cause of death in the United States—will take centerstage during Hypertension Awareness Month in May and World Hypertension Day on Thursday, May 17. Experts at the National Heart, Lung, and Blood Institute (NHLBI), where hypertension research has long been a top priority, are ava...
|
NHLBI in the Press
Researchers say they have developed a synthetic version of a natural protein called lung surfactant that restored breathing capacity to the injured lungs of rats.  The artificial substance could lead to better, cheaper treatments for lung injury in humans, they say.